Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

125.06 -0.06 (-0.05%)
Official Closing Price Updated: 4:15 PM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects. 
Via Stocktwits
Healthcare And Biotech Stocks Lag The Market Again
Biotech stocks got little help from the JPM Conference despite some recovery to the general market. 
Via Talk Markets
Topics Stocks / Equities
There May Still Be Time to Get in on These 3 Trending Biotechs
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Major Sector ETFs January Trend Trade is Here
Transportation IYT chart is incredible. The price action Friday showed the attempt to take out the January trend trade range and then failed. 
Via Talk Markets
Topics ETFs
Inflation, Soft Landing, January Trend Trade Working Out
Sugar, as shown in the weekly chart, has broken down under the 200-WMA for the first time since December 2020. However, it is holding the August 2024 low. 
Via Talk Markets
Topics Commodities ETFs Economy
Exposures Interest Rates
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% YoY. 
Via Benzinga
The Major Sector ETFs Remain Technically Intact
As long as XRT holds 78.00, it’s back where it broke out from after a massive consolidation last year. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter. 
Via Talk Markets
Topics ETFs Stocks / Equities
Happy New Year Or Is It For The Major Sector ETFs?
Russell 2000 IWM, has a few key points of support to hold. $217 is one. The 50-week moving average at around $212.45 is another. 
Via Talk Markets
Topics ETFs
Healthcare And Biotech Stocks Continue Their Slide
Biotech shares continued their slide which began in early November and got no help from small caps which also sold off through December. 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs - Buy This Dip?
​​​​​​​As we ended this week, clearly Nasdaq held up better than pretty much everything else. 
Via Talk Markets
Topics Commodities ETFs
The Major Sector ETFs Talk Turkey
Retail XRT should hold the gap up it started this past week with. If that is the case, we anticipate a move higher for the coming week. 
Via Talk Markets
Topics Currencies/Forex ETFs
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway
Biotech stocks are poised for a recovery in a seasonally strong period through January 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs - Retail Rallies
What we waited for was a weekly close over 79.20, a level we have not seen since February 2022. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
Via MarketBeat
Topics ETFs Government
Exposures Political
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation. 
Via Benzinga
Reality Sets Into The Major Sector ETFs
XRT failed to rally above the $80 level, the top of the 10-month consolidation. 
Via Talk Markets
What Do Major Sector ETFs Say Now?
KRE is back to the scene of the crime at the 65 level. Above there, we see 75 area as the next resistance. 
Via Talk Markets
Topics ETFs
What Does the Economic Modern Family Say Now?
Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election. 
Via Talk Markets
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Stock And Commodity Market Thoughts
As the SPY corrects a bit from the recent run up to all-time highs, we still have keen eyes on other sectors. 
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
Can Biotechnology Make A Seasonal Move Higher?
Currently, IBB trades beneath the July calendar range high. 
Via Talk Markets
Did the Economic Modern Family Really Go Anywhere?
​​​​​​​After rising yields and a big drop in TLT, the trend may have reversed. Here is why that is important... 
Via Talk Markets
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
Key Index And Sectors Are Inside Last Week’s Range
The ultimate technical pattern that represents indecision is when by midweek, the price range remains stuck inside the trading pattern of the week prior. 
Via Talk Markets
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Biotech Breakout: Stocks for Your Watchlist
The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. 
Via MarketBeat
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.